Griebel et al. suggested that although CRF has been recognized as a key regulator of the stress system, there is evidence that the vasopressinergic system may play an equal role in regulating the stress responses; so vasopressin V (1b) receptor antagonists may be potential treatment for depression. This evidence concerns the gene CRH and depressive disorder.